Search Results
81 items found for "China M Payne"
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
trafficking of DOR, facilitating its downregulation and influencing cellular signaling pathways essential for pain
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
September 2022 "Morphine, the most widely used analgesic, relieves severe pain by activating the μ-opioid
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
various diseases, such as idiopathic pulmonary fibrosis, cancers, cardiovascular diseases and neuropathic pain
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
leading to the development of drugs with superior efficacy and reduced side effects in heart disease, pain
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities. Investigating the potential of GalR2 as a drug target for neuropathic pain.
- Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...
evidence implicates the G-protein coupled receptor (GPCR) GPR183 in the development of neuropathic pain
- Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..
MRGPRs), a subfamily of GPCRs, are largely expressed by sensory neurons and known to modulate itch and pain
- 📰 GPCR Weekly News
Photopharmacological manipulation of amygdala metabotropic glutamate receptor mGlu4 alleviates neuropathic pain GPCRs in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Library-based screening methodology for engineering small protein GPCR ligands Paolini-Bertrand, M.
- 📰 GPCR Weekly News, June 3 to June 9, 2024
ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform GPCRs and Emotional Pain
- 📰 GPCR Weekly News, May 22 to 28, 2023
Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief.
- Therapeutic validation of an orphan G protein‐coupled receptor
Some studies have also reported GPR84 involvement in pain, atherosclerosis, and even metabolic disorders
- 📰 GPCR Weekly News, June 26 to July 2, 2023
Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential Function Identification of a potential structure-based GPCR drug for interstitial cystitis/bladder pain
- 📰 GPCR Weekly News, February 27 to March 5, 2023
has a new website Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
protein and fat synthesis GPCRs in Neuroscience Targeting sensory neuron GPCRs for peripheral neuropathic pain
- 📰 GPCR Weekly News, March 13 to 19, 2023
A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice.
- 📰 GPCR Weekly News, April 15 to 21, 2024
metamorphosis and spawning behavior in Pacific abalone The role of orphan G protein-coupled receptors in pain
- GPCR Buzz of the Week | Sep 23 - 29, 2024
framework combining molecular image and protein structural representations identifies candidate drugs for pain
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Activation and Signaling Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain
- 📰 GPCR Weekly News, June 17 to 23, 2024
Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain
- 📰 GPCR Weekly News, October 30 to November 4, 2023
inhibits purinergic P2Y2 receptor and TRPV4 to suppress astrocyte activation and to relieve neuropathic pain
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Therapeutic Targets for the Treatment of Neurological Disease s Activation of GPR55 alleviates neuropathic pain
- 📰 GPCR Weekly News
Identification of a potential structure-based GPCR drug for interstitial cystitis/bladder pain syndrome
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
clinical development Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain
- 📰 GPCR Weekly News, March 25 to March 31, 2024
receptor Satellite glial GPR37L1 and its ligand maresin 1 regulate potassium channel signaling and pain